• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病倡导组织资助临床遗传学研究:生物医学期刊中资助披露的综述。

The financing of clinical genetics research by disease advocacy organizations: A review of funding disclosures in biomedical journals.

机构信息

Department of Bioethics, Cleveland Clinic, Cleveland, Ohio 44195, USA.

出版信息

Am J Med Genet A. 2010 Dec;152A(12):3051-6. doi: 10.1002/ajmg.a.33767.

DOI:10.1002/ajmg.a.33767
PMID:21077206
Abstract

Anecdotal reports suggest that disease-advocacy groups (DAOs) participate in multiple aspects of clinical research. No systemic analysis of the extent of DAO involvement in clinical genetics research has been conducted to date. We conducted a systematic review of journal articles published in 2004 and 2005 reporting clinical research on 50 genetic diseases to assess the extent to which DAOs financed the studies reported, assisted in subject recruitment, or participated in other aspects of research. Of 513 articles, 350 (68%) included a statement regarding research support. Of these articles, 114 (33%) acknowledged DAO funding. The proportion of articles reporting financial support from a DAO varied greatly by disease. Articles reporting financial support from a DAO often identified at least one additional source of support (73%). Of the articles examined, 19 (4%) acknowledged DAO assistance with subject recruitment and 11 (2%) included an author affiliated with a DAO. DAOs provide financial support for numerous clinical research studies in genetics, often in partnership with government agencies and for-profit corporations. DAOs also participate in other aspects of clinical research, including subject recruitment. Future studies should seek to characterize these research partnerships more fully.

摘要

有传闻称,疾病倡导组织(DAOs)参与了临床研究的多个方面。迄今为止,尚未对 DAO 在临床遗传学研究中参与程度进行系统分析。我们对 2004 年和 2005 年发表的 50 种遗传疾病临床研究的期刊文章进行了系统评价,以评估 DAO 为报告的研究提供资金、协助受试者招募或参与研究其他方面的程度。在 513 篇文章中,有 350 篇(68%)对研究支持情况作了说明。在这些文章中,有 114 篇(33%)承认 DAO 提供了资金。报告 DAO 提供资金的文章比例因疾病而异。报告 DAO 资金支持的文章通常确定了至少一个额外的支持来源(73%)。在所检查的文章中,有 19 篇(4%)承认 DAO 协助了受试者招募,有 11 篇(2%)的作者隶属于 DAO。DAOs 为许多遗传学临床研究提供资金支持,这些研究通常与政府机构和营利性公司合作进行。DAOs 还参与临床研究的其他方面,包括受试者招募。未来的研究应努力更全面地描述这些研究合作关系。

相似文献

1
The financing of clinical genetics research by disease advocacy organizations: A review of funding disclosures in biomedical journals.疾病倡导组织资助临床遗传学研究:生物医学期刊中资助披露的综述。
Am J Med Genet A. 2010 Dec;152A(12):3051-6. doi: 10.1002/ajmg.a.33767.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
4
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.试验报告的统一标准(CONSORT)以及医学期刊上发表的随机对照试验(RCT)的报告完整性。
Cochrane Database Syst Rev. 2012 Nov 14;11(11):MR000030. doi: 10.1002/14651858.MR000030.pub2.
5
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
6
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Effects of consumers and health providers working in partnership on health services planning, delivery and evaluation.消费者和医疗服务提供者合作对卫生服务规划、提供和评估的影响。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD013373. doi: 10.1002/14651858.CD013373.pub2.
9
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
10
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.

引用本文的文献

1
Examining Physician Interactions with Disease Advocacy Organizations.审视医生与疾病倡导组织的互动。
AJOB Empir Bioeth. 2019 Oct-Dec;10(4):222-230. doi: 10.1080/23294515.2019.1652213. Epub 2019 Aug 26.
2
Participant-Centric Initiatives: Tools to Facilitate Engagement In Research.以参与者为中心的倡议:促进参与研究的工具
Appl Transl Genom. 2012 Dec 1;1:25-29. doi: 10.1016/j.atg.2012.07.001.
3
Focusing on Cause or Cure?: Priorities and Stakeholder Presence in Childhood Psychiatry Research.关注病因还是治疗?儿童精神病学研究中的优先事项与利益相关者参与情况
AJOB Prim Res. 2014 Jan 1;5(1):44-55. doi: 10.1080/21507716.2013.811315.